
Keywords: BDL; bile duct ligation; Mmp; matrix metalloproteinases; Timp; tissue inhibitors of metalloproteinase; NqoI; NAD(P)H quinone oxidoreductase; UDCA; ursodeoxycholic acid; PBC; primary biliary cirrhosis; GSH; glutathione; Mrp; multidrug resistance-associated